iTeos Therapeutics, Inc. Annual Operating Lease, Payments in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
iTeos Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2021 to 2023.
  • iTeos Therapeutics, Inc. Operating Lease, Payments for the quarter ending September 30, 2024 was $380K, a 20.3% increase year-over-year.
  • iTeos Therapeutics, Inc. Operating Lease, Payments for the twelve months ending September 30, 2024 was $1.48M, a 40.5% increase year-over-year.
  • iTeos Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $1.2M, a 39.7% increase from 2022.
  • iTeos Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $860K, a 12.1% increase from 2021.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.2M +$341K +39.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-06
2022 $860K +$93K +12.1% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-15
2021 $767K Jan 1, 2021 Dec 31, 2021 10-K 2022-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.